Moyes Jay M is Chief Financial Officer of Sera Prognostics, Inc.
Person profile
Roles
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
PUMA BIOTECHNOLOGY, INC.
21 Jun 24
4
PUMA BIOTECHNOLOGY, INC.
17 Jun 24
144
PUMA BIOTECHNOLOGY, INC.
13 Jun 24
4
BioCardia, Inc.
19 Oct 23
4
PUMA BIOTECHNOLOGY, INC.
15 Jun 23
144
PUMA BIOTECHNOLOGY, INC.
13 Jun 23
4
SERA PROGNOSTICS, INC.
7 Jun 23
4
SERA PROGNOSTICS, INC.
7 Mar 23
4
BioCardia, Inc.
30 Sep 22
4
PUMA BIOTECHNOLOGY, INC.
21 Jun 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Jun 24 | PBYI Puma Biotechnology | Common Stock | Grant | Acquire A | No | No | 0 | 27,000 | 0.00 | 48,322 |
13 Jun 24 | PBYI Puma Biotechnology | Common Stock | Sell | Dispose S | No | Yes | 3.3394 | 22,000 | 73.47 k | 21,322 |
18 Oct 23 | BCDA BioCardia | Stock Option Common stock | Grant | Acquire A | No | No | 0.4029 | 12,434 | 5.01 k | 41,233 |
13 Jun 23 | PBYI Puma Biotechnology | Common Stock | Grant | Acquire A | No | No | 0 | 27,000 | 0.00 | 43,322 |
13 Jun 23 | PBYI Puma Biotechnology | Common Stock | Sell | Dispose S | No | Yes | 3.4532 | 22,000 | 75.97 k | 16,322 |